Oral

[1O10m-2] Neurological Disease

Wed. Jul 29, 2020 10:00 AM - 11:00 AM Room 10

*Videos are available throughout the meeting period.

+Add all to schedule

[1O10m-2-01] USP10 inhibits dopamine-induced ROS-dependent apoptosis of neuronal cells through Nrf2/Keap1/p62 pathway

*Junya Sango¹, Kakihana Taich¹, Katsuragi Yoshinori¹, Masahiko Takahashi¹, Sergei Anisimov¹, Masahiro Fujii¹ (1. Div. of Virology. Niigata Univ. Grad. Sch. of Medical and Dental Siences, Niigata, Japan)

[1O10m-2-02] Exogenous input to the epileptic focus modulates high frequency activities at the site of stimulation: a direct single pulse stimulation study

*Shunsuke Kajikawa¹, Riki Matsumoto², Katsuya Kobayashi^1,3, Masao Matsuhahshi⁴, Yukihiro Yamao⁵, Takayuki Kikuchi⁵, Kazumichi Yoshida⁵, Ryosuke Takahashi¹, Akio Ikeda⁴ (1. Department of Neurology, Kyoto Graduate School of Medicine, 2. Division of Neurology, Kobe University Graduate School of Medicine, 3. Epilepsy Center, Cleveland Clinic, 4. Epilepsy, Movement Disorders and Physiology, Kyoto University Graduate School of Medicine, 5. Epilepsy, Movement Disorders and Physiology, Kyoto University Graduate School of Medicine)

[1O10m-2-03] Identifying high-CBD cannabis strains for epilepsy treatment

*Keren Amsalem¹, Anat Gelfand¹, Paula Shirly Berman¹, Carni Lipson¹, Gil Lewitus¹, Dedi Meiri¹ (1. Technion Israel Institute of Technology)

[1O10m-2-04] Myoclonin1 deficiency in ependymal cells increases seizure susceptibility

*TOSHIMITSU SUZUKI^1,2, KAZUHIRO YAMAKAWA^1,2 (1. Dept of Neurodevelopmental Disorder Genetics, Nagoya City Univ., Nagoya, Japan, 2. Lab. for Neurogenetics, RIKEN CBS, Wako, Japan)

Session information